• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 362780
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/20/2020
Event Type  malfunction  
Manufacturer Narrative
Additional lot number: 9256425; additional expiration date: 2019-09-13.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Additional manufacture date: 2020-09-30.
 
Event Description
It was reported that a bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml had poor barrier separation after centrifugation.The following information was provided by the initial reporter: "the costumer complained that sometimes after centrifugation , separation doesn¿t occur at all and the gel just come down only after second centrifugation the separation occurred and even then not always they get concentrated mononuclear cells layer but dispersed layer.In other cases after one centrifugation the mononuclear cells layer comes out dispersed".
 
Manufacturer Narrative
H.6.Investigation summary: bd had not received samples, but photos were provided by the customer facility for investigation.The photos were evaluated and the customer's indicated failure mode for low yield with the incident lot was observed.A review of the device history record was completed for the incident lot and, based on this review, all product specifications and requirements for lot release were met; there were no related quality non-conformances during manufacturing of the product.Bd has initiated further investigation relating to this issue through capa.1092363 the investigation is still on-going and improvements will be made as the potential causes of this issue are identified.
 
Event Description
It was reported that a bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml had poor barrier separation after centrifugation.The following information was provided by the initial reporter: "the costumer complained that sometimes after centrifugation , separation doesn¿t occur at all and the gel just come down only after second centrifugation the separation occurred and even then not always they get concentrated mononuclear cells layer but dispersed layer.In other cases after one centrifugation the mononuclear cells layer comes out dispersed.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
MDR Report Key9683347
MDR Text Key189176093
Report Number1917413-2020-00086
Device Sequence Number1
Product Code JCF
Combination Product (y/n)N
PMA/PMN Number
K891407
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 02/26/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date04/30/2020
Device Catalogue Number362780
Device Lot Number9087924
Was Device Available for Evaluation? No
Date Manufacturer Received01/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-